![]() |
市场调查报告书
商品编码
1746730
2025-2033年日本行动医疗市场报告(按组件、服务、参与者和地区划分)Japan mHealth Market Report by Component, Service, Participant, and Region 2025-2033 |
2024年,日本行动医疗市场规模达72亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到514亿美元,2025-2033年期间的复合年增长率(CAGR)为22.7%。领先企业广泛采用创新技术来支持医疗保健产业,是推动市场成长的主要动力。
行动医疗 (mHealth) 是电子医疗领域的一个多元化分支,利用行动装置和无线基础设施收集病患资料。收集的资料旨在实现精准诊断,从而辅助诊断和治疗各种疾病。 mHealth 在增强患者依从性和沟通能力、实现远距患者监护以及帮助患者安全地与医疗服务提供者沟通和安排预约方面发挥着重要作用。因此,它在医疗供应链管理、诊断和治疗流程支援、慢性病监护和管理以及提升个人健康意识等方面有着广泛的应用。目前,mHealth 技术因其提供居家患者监护服务而获得广泛认可,尤其是在老年人群体中。
日本的行动医疗市场正经历显着成长,这主要得益于几个关键因素。其中一个突出的驱动因素是日本人口的快速老化,这导致对可透过行动装置便捷存取的远距病患监护和医疗保健服务的需求不断增长。这种人口结构的变化使得人们更加重视居家照护和预防性保健措施,这使得行动医疗技术变得至关重要。此外,日本强大的技术基础设施和智慧型手机的广泛普及为行动医疗解决方案的蓬勃发展提供了有利环境。行动医疗应用程式和服务的便利性和可近性得到了患者和医疗服务提供者的一致好评。患者可以使用行动装置追踪自身健康状况、获取医疗资讯并与医疗专业人员沟通,而医疗服务提供者则可以从更高的患者参与度和即时资料监测中受益。此外,持续的新冠疫情加速了日本远距医疗和行动医疗解决方案的普及。远距会诊和监护的需求凸显了行动医疗技术在确保护理连续性的同时最大程度降低病毒传播风险的重要性。此外,支持将行动医疗融入医疗保健生态系统的政府措施和法规预计将在未来几年推动市场成长。
市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
Japan mHealth market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.4 Billion by 2033, exhibiting a growth rate (CAGR) of 22.7% during 2025-2033. The widespread adoption of innovative technologies by leading players to support the healthcare industry is primarily driving the market growth.
Mobile health (mHealth) represents a diverse sector within electronic health, involving the utilization of mobile devices and wireless infrastructure to gather patient data. The data collected serves the purpose of achieving precise outcomes that aid in the diagnosis and treatment of various medical conditions. mHealth plays a role in enhancing medication adherence and communication, enabling remote patient monitoring, and empowering patients to securely communicate with healthcare service providers and arrange appointments. Consequently, it finds broad applications in healthcare supply chain management, providing support for diagnostic and treatment procedures, monitoring and managing chronic illnesses, and fostering increased health awareness among individuals. Presently, mHealth technology is gaining widespread recognition for delivering home-based patient monitoring services, particularly among the elderly population.
The mHealth market in Japan is experiencing notable growth driven by several key factors. One prominent driver is the country's rapidly aging population, which has resulted in an increased demand for remote patient monitoring and healthcare services that can be conveniently accessed through mobile devices. This demographic shift has led to a greater emphasis on home-based care and preventive health measures, making mHealth technologies highly relevant. Moreover, Japan's robust technological infrastructure and widespread smartphone adoption provide a favorable environment for mHealth solutions to flourish. The convenience and accessibility offered by mobile health applications and services have resonated well with both patients and healthcare providers. Patients can use mobile devices to track their health, access medical information, and communicate with healthcare professionals, while healthcare providers benefit from improved patient engagement and real-time data monitoring. Additionally, the ongoing COVID-19 pandemic has accelerated the adoption of telehealth and mHealth solutions in Japan. The need for remote consultations and monitoring has underscored the importance of mHealth technologies in ensuring continuity of care while minimizing the risk of virus transmission. Furthermore, government initiatives and regulations that support the integration of mHealth into the healthcare ecosystem are expected to fuel the market growth in the coming years.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.